Home › Therapeutic areas › Immunology › Systemic Sclerosis
Systemic Sclerosis (4 companies)
Companies with an active program in Systemic Sclerosis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | ImmunologyOncology Rare | 1 | Phase 2 | 12 |
| ARTV | Artiva Biotherapeutics, Inc. | DermatologyImmunologyOncologyRenal Rare | 1 | Phase 2 | 16 |
| CABA | Cabaletta Bio, Inc. | DermatologyImmunologyNeurologyRenal Rare | 1 | Phase 1 | 8 |
| IPSC | Century Therapeutics, Inc. | ImmunologyMetabolicRenal Rare | 2 | Phase 1 | 11 |
No companies match.